Oric Pharmaceuticals
ORIC
ORIC
64 hedge funds and large institutions have $192M invested in Oric Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.69% less ownership
Funds ownership: 82.63% → 81.94% (-0.69%)
16% less funds holding
Funds holding: 76 → 64 (-12)
67% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 18
Holders
64
Holding in Top 10
5
Calls
$1.04M
Puts
$190K
Top Buyers
| 1 | +$2.09M | |
| 2 | +$1.72M | |
| 3 | +$1.44M | |
| 4 |
MAM
Monaco Asset Management
Monaco
|
+$1.27M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.17M |
Top Sellers
| 1 | -$2.83M | |
| 2 | -$1.95M | |
| 3 | -$1.42M | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$1.1M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$879K |